• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » FDA clears Carescape Canvas patient monitoring platform from GE HealthCare

FDA clears Carescape Canvas patient monitoring platform from GE HealthCare

April 20, 2023 By Sean Whooley

GE HealthCare Carescape Canvas patient monitoring platform
The Carescape Canvas patient monitoring platform. [Image courtesy of GE HealthCare]
GE HealthCare (Nasdaq:GEHC) announced today that it received FDA 510(k) clearance for its Carescape Canvas patient monitoring platform.

Carescape Canvas offers precise, flexible patient care. Together with Carescape One, it makes up part of an adaptable ecosystem set for scaling up and scaling down monitoring capabilities. This comes based on the acuity of each individual patient. The platform delivers monitoring on a standardized platform that drives enterprise efficiency and ease of service.

A FlexAcuity solution, Carescape Canvas features smart parameter technology for patients at all levels of acuity. The platform offers flexibility, standardization and ease of use. It leverages micromodules that connect with standardized medical USB technology. Adding or disconnecting cables equipped for various configuration enables more efficient care based on patient needs, GE HealthCare said.

With flexible, easy-to-configure software and interchangeable frames, it enables quick redeployment of devices across hospitals, too.

“This new monitoring ecosystem has the potential for a hospital to have one single unified approach to patient monitoring that can be easily tailored for each patient,” said Neal Sandy, GM, monitoring solutions, GE HealthCare. “GE HealthCare is committed to offering flexible solutions that enable care teams to focus on the patient, not the technology. Carescape Canvas’ innovative approach, where software and patient parameters can change in a very nimble manner, enable a standardized ecosystem that can adapt to changing healthcare needs.”

More about the latest GE HealthCare patient monitoring offering

GE HealthCare developed and tested Carescape Canvas with the rest of its ecosystem. That includes current devices and prior versions used across hospitals today. Backward compatibility enables healthcare systems to upgrade to the latest capabilities at their own pace, the company said.

Additional development features included sustainability. GE HealthCare developed Carescape Canvas with a 53% reduction in packaging volume. It also offers a 48% reduction in packaging weight compared to a previous generation monitor and a 25% energy consumption reduction against prior models. GE HealthCare’s Helsinki, Finland site utilizes 100% renewable wind electricity to manufacture the systems, too.

Carescape Canvas initially received European approval in June 2022.

Filed Under: 510(k), Business/Financial News, Digital Health, Featured, Food & Drug Administration (FDA), Health Technology, Hospital Care, Patient Monitoring, Regulatory/Compliance, Software / IT Tagged With: FDA, GE Healthcare

More recent news

  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • FDA posts alert for Edwards Lifesciences mitral valve delivery system after patient death
  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy